Riskpilot← Back to searchSign inGet full accessUPVISER AS
ASActiveOrg 992869917Sandviksveien 26, 1363 HøvikWholesale of pharmaceutical and medical goods · NACE 4646Est. 20080 employeeswww.upviser.com
Revenue 2021
NOK 2,5M
-85% vs 2020
EBITDA margin
-19.5%
-125% vs 2020
Equity ratio
24.5%
Financial strength
Net profit 2021
NOK -492K
-133% vs 2020
| Revenue | NOK 2,5M | -85% |
| EBITDA | NOK -490K | -125% |
| Net profit | NOK -492K | -133% |
| Total assets | NOK 7,6M | +0% |
| Equity | NOK 1,9M | -57% |
| Employees | 0 | — |
Legal name
UPVISER AS
Org number
992869917
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
5. august 2008
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Import og markedsføring av medisinsk utstyr.
Address
Sandviksveien 26, 1363 Høvik
Website
www.upviser.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 173 | 5 062 | 6 751 | 8 894 | 11 832 | 13 210 | 11 428 | 13 883 | 15 721 | 14 093 | 15 770 | 14 969 | 16 262 | 2 513 |
| Staff expenses | −631 | −1 527 | −1 438 | −1 844 | −2 395 | −2 706 | −2 136 | −2 533 | −2 497 | −2 109 | −2 790 | −3 918 | −3 227 | −808 |
| EBITDA | −692 | −459 | 314 | 847 | 1 258 | 1 159 | 1 | 284 | 1 542 | 2 931 | 3 268 | 464 | 1 989 | −490 |
| Depreciation & amort. | −0 | −0 | −7 | −10 | −10 | −3 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −692 | −459 | 306 | 837 | 1 248 | 1 156 | 1 | 284 | 1 542 | 2 931 | 3 268 | 464 | 1 989 | −490 |
| Net financials | −258 | 209 | −59 | 58 | −24 | −57 | −127 | 19 | 80 | −5 | 7 | −33 | −73 | −2 |
| Profit before tax | −949 | −250 | 248 | 896 | 1 224 | 1 099 | −125 | 303 | 1 622 | 2 926 | 3 275 | 431 | 1 916 | −492 |
| Tax | −0 | −0 | −0 | 12 | 346 | 321 | −0 | 91 | 429 | 723 | 775 | 123 | 434 | −0 |
| Net profit | −949 | −250 | 248 | 884 | 878 | 779 | −125 | 211 | 1 193 | 2 203 | 2 500 | 309 | 1 482 | −492 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 253 | 2 569 | 2 722 | 3 257 | 4 630 | 4 576 | 4 680 | 4 275 | 4 318 | 6 734 | 7 046 | 6 735 | 7 656 | 7 641 |
| Equity | −828 | −1 078 | −831 | 53 | 931 | 1 217 | 1 092 | 1 303 | 1 696 | 2 899 | 3 900 | 2 708 | 4 306 | 1 870 |
| Long-term debt | 1 614 | 1 373 | 1 867 | 1 645 | 1 209 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 468 | 2 275 | 1 686 | 1 558 | 2 490 | 3 359 | 3 588 | 2 972 | 2 622 | 3 835 | 3 146 | 4 027 | 3 350 | 5 772 |
| Total debt | 2 081 | 3 648 | 3 553 | 3 204 | 3 699 | 3 359 | 3 588 | 2 972 | 2 622 | 3 835 | 3 146 | 4 027 | 3 350 | 5 772 |
EBITDA margin
-19.5%
This company
15.8%
Market median
-223% vs market
20082021
Equity ratio
24.5%
This company
38.2%
Market median
-36% vs market
20082021
Return on equity
-26.3%
This company
18.4%
Market median
-243% vs market
20082021
Net profit margin
-19.6%
This company
8.1%
Market median
-342% vs market
20082021
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20082021
Debt / equity
3.09×
This company
0.62×
Market median
-398% vs market
20082021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-11-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2019-11-01 – 2020-10-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2018-11-01 – 2019-10-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2017-11-01 – 2018-10-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2016-11-01 – 2017-10-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2015-11-01 – 2016-10-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2014-11-01 – 2015-10-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2013-11-01 – 2014-10-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2012-11-01 – 2013-10-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2011-11-01 – 2012-10-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2010-11-01 – 2011-10-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2009-11-01 – 2010-10-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-10-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-06-02 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NJ Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
JT Deputy Member | Deputy Member | 2019 | — | — |
TD Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of UPVISER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niko Jyri Suominen | Chief Executive Officer | 0 companies |
| Jorma Tapani Tiili | Deputy Member | 0 companies |
| Trond Dahl Hansen | Chief Executive Officer | 0 companies |
| Trond Vegard Lamøy | Chairman | 0 companies |
| Rune Veum | Board of Directors | 0 companies |